Global Innovative Platforms (GIPL) Cash from Operations (QoQ) (2021 - 2026)
Powered by 
Analysis
Global Innovative Platforms (GIPL) Cash from Operations (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -118.65% |
| Mar 31, 2026 | 183.96% |
| Dec 31, 2025 | -93.61% |
| Sep 30, 2025 | -139.08% |
| Jun 30, 2025 | -191.16% |
| Mar 31, 2025 | 139.35% |
| Dec 31, 2024 | -47.62% |
| Sep 30, 2024 | -78,997.27% |
| Jun 30, 2024 | 83.01% |
| Mar 31, 2024 | 89.49% |
| Dec 31, 2023 | 81.03% |
| Sep 30, 2023 | -851.19% |
| Jun 30, 2023 | 77.83% |
| Mar 31, 2023 | 25.98% |
| Dec 31, 2022 | -227.58% |
| Sep 30, 2022 | 667.11% |
| Sep 30, 2021 | -99.81% |
| Jun 30, 2021 | 228.08% |
| Mar 31, 2021 | -261.45% |